Learn about the INTUNE Clinical Trial with Director of Clinical Development at Harmony Biosciences

Learn more about the INTUNE study, currently being conducted by Harmony Biosciences, to evaluate the safety and efficacy of pitolisant, an investigational medication for treating excessive daytime sleepiness (EDS) in people with idiopathic hypersomnia age 18 years or older. For more information or to find a participating clinical site visit: NCT05156047 at clinicaltrials.gov or visit www.intuneihstudy.com.
Be the first to comment